Biotage Acquires ATDBio for DNA and RNA Oligonucleotide Synthesis
Biotage AB has acquired ATDBio and strengthened its position in DNA and RNA Oligonucleotide synthesis and purification.
Biotage Acquires ATDBio and Strengthens its Position in DNA and RNA Oligonucleotide Synthesis and Purification
Biotage AB has today entered into an agreement to acquire all outstanding shares in the privately held company ATDBio Limited based in Oxford and Southampton, UK. The acquisition of ATDBio adds import...
Adoption of the Biotage® Flash 400 Reduces Process Costs
Large-scale chromatography is often the only solution to the purification of valuable drug compounds in the pharmaceutical industry. In many cases, a commercially available purification system specifi...
Biotage® Extrahera™ LV-200 Launched
Biotage are pleased to announce the launch of the new Biotage® Extrahera™ LV-200, is a GLP capable, automated sample preparation workstation dedicated to 96-well arrays for microelution technologies a...
Biotage® PhyPrep Maxi Mega Giga Launched
Biotage are pleased to announce the launch of the Biotage® PhyPrep, an automated solution for the endotoxin-free purification of plasmids on the Maxi, Mega and Giga scales. Visit our Drug Discovery pr...
Collaborating with Croda in the Global COVID-19/mRNA Vaccine Response
Read how Biotage collaborated with Croda to scale up the purification of lipids used in the manufacturing of mRNA (messenger RNA) vaccines. The use of Biotage automated laboratory scale purification s...
Biotage TurboVap® 96 Dual Launched
The TurboVap® series of evaporators is an established market leader across the globe. Now, with the launch of the new TurboVap® 96 Dual, Biotage expands the family and re-defines evaporation. Our new ...
Press Release: Biotage Awarded Gold Sustainability Medal by EcoVadis
Biotage is committed to sustainability at every level within the company and within every customer relationship. EcoVadis, a leading producer of supplier sustainability ratings, recently recognize thi...